Natixis
- SEC CIK
- 0001274981
- Latest filing
- Aug 13, 2026
AUPH holding history
Aurinia Pharmaceuticals Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AUPH overviewAll 13F holders of AUPHFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −5,500−100.0% | Sold out | Holders |
| Q4 2024 | 5,500 | $49.4K | <0.1% | +5,500 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −50,717−100.0% | Sold out | Holders |
| Q1 2024 | 50,717 | $254.1K | <0.1% | −27,897−35.5% | Reduced | Holders |
| Q4 2023 | 78,614 | $706.7K | <0.1% | −217,541−73.5% | Reduced | Holders |
| Q3 2023 | 296,155 | $2.30M | <0.1% | +33,899+12.9% | Added | Holders |
| Q2 2023 | 262,256 | $2.54M | <0.1% | −963,231−78.6% | Reduced | Holders |
| Q1 2023 | 1,225,487 | $13.4M | 0.1% | +250,544+25.7% | Added | Holders |
| Q4 2022 | 974,943 | $4.21M | <0.1% | +846,998+662.0% | Added | Holders |
| Q3 2022 | 127,945 | $977.0K | <0.1% | −872,055−87.2% | Reduced | Holders |
| Q2 2022 | 1,000,000 | $9.91M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,000,000 | $12.4M | <0.1% | +500,000+100.0% | Added | Holders |
| Q4 2021 | 500,000 | $11.4M | <0.1% | +500,000 | New | Holders |